Companies / Brazil
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Boehringer Eyes Brazilian OTC Market
August 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
German drugmaker Boehringer Ingelheim (BI) is set to expand its presence in the Brazilian OTC market, as it looks to bolster its portfolio. The company markets several market-leading brands including the anti-spasmodic Buscopan and Mucusolvan, and has already boosted its marketing budget 17% to US$75mn in